ISRCTN98382551已完成未知
se of recombinant activated Factor Seven in bleeding extracorporeal membrane oxygenation patients post cardiac surgery: a randomised prospective study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Post cardiac surgery patients
排除标准
- •Not provided at time of registration
研究者
相似试验
撤回
不适用
The role of Factor-VII activating protease in the generation of bradykinin in patients with hereditary angioedema10040792hereditary angioedemaNL-OMON37687Academisch Medisch Centrum30
进行中（未招募）
1 期
Recombinant Factor VIIa for acute bleeding in the brain (Hemorrhagic Stroke) administered at earliest Time - (FASTEST) TrialEUCTR2019-003722-25-GBniversity of Cincinnati860
已完成
3 期
Recombinant Factor VIIa (NovoSeven) on Restoring Coagulation ActivationHemophilia ANCT00375323Medical University of Vienna
终止
1 期
Factor VII, Prothrombin Complex Concentrate, and Fresh Frozen Plasma in Warfarin-Related Intracranial HemorrhageIntracranial HemorrhageNCT00770718University of Utah2
已完成
不适用
Recombinant Activated Factor VII in the Management of Massive Bleeding in Hospital Universiti Sains MalaysiaMassive HemorrhageMassive Blood LossMassive Blood Transfusion ThrombocytopeniaNCT03251547Universiti Sains Malaysia76